Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
38.10%
↓ 100% vs avg
Percentile
P77
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
10219.20%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 38.10% |
| Q2 2025 | 98.46% |
| Q1 2025 | -4757.14% |
| Q4 2024 | 99.14% |
| Q3 2024 | 24.74% |
| Q2 2024 | -46.03% |
| Q1 2024 | 30.86% |
| Q4 2023 | -1.74% |
| Q3 2023 | -49.73% |
| Q2 2023 | 28.31% |
| Q1 2023 | -18.86% |
| Q4 2022 | 15.11% |
| Q3 2022 | -64.00% |
| Q2 2022 | 17.79% |
| Q1 2022 | -2860.82% |
| Q4 2021 | 95.39% |
| Q3 2021 | 17.68% |
| Q2 2021 | -62.14% |
| Q1 2021 | -738.83% |
| Q4 2020 | 88.16% |
| Q3 2020 | -11.67% |
| Q2 2020 | -409.32% |
| Q1 2020 | 182.68% |
| Q4 2019 | -213.26% |
| Q3 2019 | -16.92% |
| Q2 2019 | -88.36% |
| Q1 2019 | 422138.40% |
| Q4 2018 | 18.00% |
| Q3 2018 | -31.10% |
| Q2 2018 | -27.59% |
| Q1 2018 | 20.56% |
| Q4 2017 | 20.75% |
| Q3 2017 | -11.00% |
| Q2 2017 | 39.40% |
| Q1 2017 | 97.79% |
| Q4 2016 | -4385.24% |
| Q3 2016 | 11.61% |
| Q2 2016 | 29.14% |
| Q1 2016 | 97.20% |
| Q4 2015 | -647.63% |